Entries of Wenter, V. on the publication server
 | Up a level |
Number of items: 3.
2020
Unterrainer, M., Fleischmann, D. F., Vettermann, F., Ruf, V., Kaiser, L., Nelwan, D., Lindner, S., Brendel, M., Wenter, V., Stöcklein, S., Herms, J., Milenkovic, V. M., Rupprecht, R., Tonn, J. C., Belka, C., Bartenstein, P., Niyazi, M. and Albert, N. L.
(2020)
TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study.
European Journal of Nuclear Medicine and Molecular Imaging 47 (6), pp. 1368-1380.
Fulltext not available.
2019
Unterrainer, Marcus, Fleischmann, D. F., Diekmann, C., Vomacka, L., Lindner, S., Vettermann, F., Brendel, M., Wenter, V., Ertl-Wagner, B., Herms, J., Wetzel, C., Rupprecht, R., Tonn, J. C., Belka, C., Bartenstein, P., Niyazi, M. and Albert, Nathalie L.
(2019)
Comparison of 18F-GE-180 and dynamic 18F-FET PET in high grade glioma: a double-tracer pilot study.
European Journal of Nuclear Medicine and Molecular Imaging 46 (3), pp. 580-590.
Fulltext not available.
2017
Albert, Nathalie L., Unterrainer, M., Fleischmann, D. F., Lindner, S., Vettermann, F., Brunegraf, A., Vomacka, L., Brendel, M., Wenter, V., Wetzel, C. 
, Rupprecht, R., Tonn, J.-C., Belka, C., Bartenstein, P. and Niyazi, M.
(2017)
TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma.
European Journal of Nuclear Medicine and Molecular Imaging 44 (13), pp. 2230-2238.
Fulltext not available.
, Rupprecht, R., Tonn, J.-C., Belka, C., Bartenstein, P. and Niyazi, M.
(2017)
TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma.
European Journal of Nuclear Medicine and Molecular Imaging 44 (13), pp. 2230-2238.
Fulltext not available.